MEET THE TEAM
The Telluride Medical Partners team is comprised of business entrepreneurs and medical device startup experts who are experienced in combining both business and technical knowledge, upstream market identification, monetization strategies, and execution towards the development and growth of medical device companies.
Chief Executive Officer
Eric Wells is an experienced CEO, strategist, and investor with expertise in acquiring and managing companies. He resides on the boards of or is an advisor to companies in the medical device, real estate, tech and travel tech industries, and he has had a long and successful career developing commercial and residential real estate projects. Wells began his career as a builder, successfully completing a number of commercial and residential property developments.
Chief Financial Officer
Bryan Ziegler comes to TMP from multi-national banking firm Credit Suisse where he worked in its Houston, TX office. Prior to Credit Suisse, Ziegler worked for Philadelphia-based health benefits consultant, Wellness Coaches USA, serving two different Fortune 500 companies in Houston, TX and Wichita, KS. Bryan received an MBA from the Jones Graduate School of Business at Rice University with concentrations in Finance and Entrepreneurship.
Senior Vice President
Kelvin Ning brings a unique blend of more than 12 years of startup medical device experience from the Silicon Valley. Ning was the previous Director of R&D at Bacchus Vascular (now Covidien/ Medtronic), and head of engineering at several other small firms. Ning was also head of manufacturing, director of product marketing, conducted clinical trials in Europe, and is a certified reimbursement researcher.
Ian Mullet, PHD
Ian Millet has over 25 years of professional experience and serves as Vice President of Regulatory & Quality for ARC Medical Devices. He has extensive experience assisting clients in introducing new medical products to market both in the US and abroad while providing regulatory and market analysis for biologics, drug/combination devices, medical devices, and IVDs for clients worldwide.
Director R&D, Nectero Medical
Throughout his career Terry Buelna has garnered over 35 patents, and more importantly, 20+ products that have been successfully used in surgery. Career highlights include co-founding Applied Medical where he spearheaded the Urology and Laparoscopy divisions, and forming his own company, Abacus, that was acquired by Bard Cardiology in less than two years. Most recently Buelna created Verve Medical.
Ronan Jenkinson grew up in Ireland and moved to California shortly after graduating from Dublin Institute of Technology. Jenkinson began his professional career at a small start-up in Silicon Valley, specializing in medical device development and manufacturing. Jenkinson has extensive experience with laparoscopic instruments, surgical instruments, ophthalmic stent delivery systems, respiratory devices, 3D printing, laser welding, and custom tooling and fixtures.
Blake Sakran graduated from Washington University in St. Louis with a B.S. in Biomedical Engineering a M.S. in Electrical Engineering. Sakran worked in a sleep research lab while obtaining both of his degrees and his professional experience has been focused on medical device development. Prior to joining TMP he was part of the Chrona team and focused on product development while gaining extensive experience within the medical device startup industry.
TMP ADVISORY TEAM
Jack Springer is a 25-year veteran of the healthcare industry with global experience in general management, sales, and marketing for medical devices and diagnostics. Springer has a proven track record in strategic planning as well as sales and marketing execution. Springer provides guidance and expertise to both small and large companies to enable them to achieve their next stage of growth or overcome market and other challenges that their business may currently be facing.
Bruce Roberts is a dedicated advisor and investor in the life sciences sector, with a particular focus and expertise in medical technology and over 20 years of experience in the space. On the advisory side, Roberts is a senior partner overseeing the medtech M&A practice at RM Global Partners LLC, a leading boutique investment bank. On the principal side, Roberts is investing in the medtech space through Health Family Capital, his family office, alongside other family office and strategic investors.
Robert Whirley is a proven medical device entrepreneur and leader with 20 years of experience and in-depth expertise in cardiovascular medical devices. He has a demonstrated ability to build teams and take products from concept to global commercialization and is effective in using cross-functional collaboration to achieve company objectives. Whirley has a thorough understanding of U.S. and European clinical trial and regulatory approval processes.
Robert Bersin, MD
Advisor, Nectero Medical
Robert Bersin, MD is a cardiologist in Bellevue, Washington and is affiliated with multiple hospitals in the area, including Grays Harbor Community Hospital and Swedish Medical Center-Cherry Hill. He received his medical degree from David Geffen School of Medicine at UCLA and has been in practice for more than 20 years. Bersin is one of four doctors at Grays Harbor Community Hospital and one of 67 at Swedish Medical Center-Cherry Hill who specialize in Cardiovascular Disease.
Matthew J. Eagleton, MD
Advisor, Nectero Medical
Dr. Eagleton is the Chief of Vascular and Endovascular Surgery at the Massachusetts General Hospital and Co-director of the Fireman Vascular Center. Dr. Eagleton received his medical degree (1994) and completed his residency (General Surgery, 2000) from the University of Rochester. He completed specialty training in Vascular Surgery at the University of Michigan in 2002 and obtained advanced training in endovascular procedures at the Cleveland Clinic.
Sean English, MD
Advisor, Nectero Medical
Sean English, MD became the 20th Wylie Scholar for his research project to neutralize the body’s signaling mechanisms which cause abdominal aortic aneurysms (AAA). He is currently the Assistant Professor of Surgery
Vascular Surgery Section
Washington University School of Medicine. Dr. English is the 3rd Wylie Scholar from Washington University, a testament to the program’s commitment to career mentorship.
John H. Rundback, MD
Advisor, Capture Vascular
John H. Rundback, MD is a renowned interventional radiologist in practice for nearly two decades and is the Director of the Interventional Institute at Holy Name Medical Center. He is board-certified in radiology and holds a Certificate of Added Qualification in Angiography and Interventional Radiology. He has been named as a Top Doctor by Castle Connolly. Dr. Rundback's research interests include peripheral arterial, carotid and aortic aneurysmal disease, deep venous thrombosis and varicose veins.
Venkatesh G. Ramaiah, MD, FACS
Advisor, Capture Vascular
Venkatesh G. Ramaiah, MD specializes in endovascular and vascular surgery. He treats conditions such as complications with blood vessels and intervenes to prevent aneurysms and heart attacks. Additionally, Dr. Ramaiah conducts endovascular research at the Arizona Heart Institute. He is currently the medical director of the Arizona Heart Hospital. He is also the director of Peripheral and Endovascular Research at the Arizona Heart Institute, and is the principal investigator in numerous research studies and protocols.
Ty Hu is the Founder and Executive Managing Partners of Gateway Medical Innovation Center in Shanghai. He is also the founder and CEO of InnoMed, a Santa Clara, CA and Shanghai-based medical device company. Hu has a broad academic and industrial experience and has managed numerous technology innovation and product development programs. Hu completed his post-doctoral training in medical oncology at the Yale School of Medicine and worked at the Cancer Institute of New Jersey before joining the medical device industry.
Jack Wolinetz has had a long and distinguished career working in the healthcare industry. He began with the Great American Insurance Company in 1964 before joining Pfizer in 1966. In 1975, Wolinetz moved to Bristol-Myers Squibb, rising to the position of president of Bristol-Myers Squibb China. He retired from Bristol Meyer Squibb in 1998. Since then, Wolinetz has worked as a consultant, advising a range of prominent pharmaceutical and healthcare companies on a multitude of issues.
Regulatory & Quality Advisor
Greg Mathison has over 30 years of experience in the medical device industry. Mathison has experience developing and implementing creative global regulatory strategies; developing, implementing and auditing quality systems in accordance with FDA; interfacing and negotiating with FDA and international regulatory agencies; and organizing and submitting 510(k), IDE and PMA applications to FDA and technical dossiers to foreign governments, among other specialties.